Veradigm Inc. MDRX
At closeFeb 5, 2026, 4:00 PM EST
- YTD
- -1.25%
- 1 year
- +7.73%
- Market cap
- 516.62M
- Revenue (ttm)
- 1.53B
- Profit margin
- 3.97%
- EPS (ttm)
- -2.63
- Shares out
- 109.26M
- Forward P/E
- 6.52
- YTD return
- -1.25%
- 1-year return
- +7.73%
- Volume
- 9.96K
- Avg volume
- 87.53K
- Open
- 4.80
- Previous close
- 4.60
- Day's range
- 4.80 – 4.89
- 52-week range
- 3.25 – 6.00
- Beta
- 0.70
- Analysts
- Buy
- Price target
- 15.00 (+216.5%)
- Earnings date
- Jan 4, 2024
Key statistics
- Enterprise value
- 380.68M
- PEG ratio
- -0.62
- Price / sales
- 0.44
- Price / book
- 0.57
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 5.00%
- Free cash flow
- 155.57M
- Total cash
- 492.60M
- Total debt
- 218.81M
- Return on equity
- 8.93%
- Short % of float
- 0.00%
- 50-day average
- 9.22
- 200-day average
- 11.81
Analyst view
Consensus: buy
- Target (low)
- 10.00
- Target (mean)
- 15.00
- Target (high)
- 26.00
- Strong buy6
- Buy6
- Hold7
- Sell1
- Strong sell0
Next earnings
Jan 4, 2024
Expected Jan 4, 2024. Consensus EPS estimate 0.27.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jan 4, 2024 | Sep 1, 2023 | 0.22 | — | — | — |
| Oct 5, 2023 | Jun 1, 2023 | 0.20 | — | — | — |
| Jul 6, 2023 | Mar 1, 2023 | 0.14 | — | — | — |
| Nov 3, 2022 | Sep 1, 2022 | 0.19 | 0.23 | +0.04 | +21.05% |
| Aug 4, 2022 | Jun 1, 2022 | 0.16 | 0.18 | +0.02 | +12.50% |
| May 5, 2022 | Mar 1, 2022 | 0.20 | 0.13 | -0.07 | -35.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 9, 2023 | Stephens & Co. | reit | Equal-Weight | Equal-Weight |
| Jul 5, 2023 | Argus Research | down | Buy | Hold |
| Apr 11, 2023 | Stephens & Co. | init | — | Equal-Weight |
| Jan 31, 2023 | Piper Sandler | down | Overweight | Neutral |
| Dec 6, 2022 | Argus Research | up | Hold | Buy |
| Nov 17, 2022 | JP Morgan | main | — | Underweight |
About Veradigm Inc.
Veradigm Inc., a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
- Country
- United States
- Website
- veradigm.com
News
Veradigm (NASDAQ:MDRX) Share Price Crosses Below 200 Day Moving Average – Here’s Why
Veradigm Product Portfolio Achieves HITRUST i1 Certification
Veradigm (NASDAQ:MDRX) & Augmedix (OTCMKTS:AUGX) Financial Comparison
Veradigm to Participate in Two Upcoming Investor Conferences
Veradigm Inc. (MDRX) Discusses Progress on SEC Filings, Relisting Efforts and Strategic Update Transcript
Veradigm Files 2023 and 2024 Form 10-K
Veradigm Survey: Independent Practices Rely on Technology to Stay Independent
Veradigm Receives KLAS 2026 Points of Light Award for Embedding SDOH Data in Provider EHR Workflows
Veradigm Doubles India-Based Employee Footprint, Adds New Managing Director
Veradigm: You Can't Fall Off The Floor
Your note
Sign in to keep a note on MDRX — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALTMAN ELIZABETH ANN | Director | Stock Award(Grant) | Jun 26, 2022 | 35,552 |
| GARRISON P GREGORY | Director | Stock Award(Grant) | Jun 26, 2022 | 60,569 |
| HAMMOND LISA | Officer | Stock Award(Grant) | Feb 25, 2024 | 70,416 |
| JAMES THOMAS LANGAN | President | Stock Award(Grant) | Feb 25, 2024 | 180,659 |
| JONES LEAH | Chief Financial Officer | Sale | Sep 12, 2022 | 98,362 |
| JUDGE JONATHAN JAMES | Director | Stock Award(Grant) | Jun 26, 2022 | 132,487 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 18.05% | 19,720,678 | 248.48M | Jun 29, 2023 |
| Vanguard Group Inc | 13.00% | 14,204,004 | 178.97M | Jun 29, 2023 |
| Dimensional Fund Advisors LP | 8.27% | 9,035,018 | 113.84M | Jun 29, 2023 |
| State Street Corporation | 3.69% | 4,034,005 | 50.83M | Jun 29, 2023 |
| Shaw D.E. & Co., Inc. | 3.49% | 3,816,655 | 48.09M | Jun 29, 2023 |
| William Blair Investment Management, LLC | 3.43% | 3,751,567 | 47.27M | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Core S&P Smallcap ETF | 6.75% | 7,376,957 | 96.93M | Sep 29, 2023 |
| Vanguard Total Stock Market Index Fund | 2.97% | 3,246,839 | 40.91M | Jun 29, 2023 |
| Vanguard Small-Cap Index Fund | 2.45% | 2,679,659 | 33.76M | Jun 29, 2023 |
| DFA U.S. Small Cap Value Series | 2.28% | 2,491,484 | 33.68M | Jul 30, 2023 |
| iShares Russell 2000 ETF | 2.28% | 2,494,903 | 33.38M | Aug 30, 2023 |
| Undiscovered Managers Behavioral Value Fund | 1.93% | 2,112,954 | 26.62M | Jun 29, 2023 |
